During his tenure at Merck, Gilmartin's holdings fluctuated significantly. At one point, the value of his vested stock options soared to nearly $26.25 million due to strategic company decisions, such as the spin-off of Medco Health. This strategic choice not...

During his tenure at Merck, Gilmartin's holdings fluctuated significantly. At one point, the value of his vested stock options soared to nearly $26.25 million due to strategic company decisions, such as the spin-off of Medco Health. This strategic choice not only helped the company streamline operations but also resulted in a substantial increase in Gilmartin's wealth from stock options. As of his departure in 2005, he had stock options covering 250,000 shares at a relatively low exercise price of $31.84, suggesting that he had significant confidence in the company's future. Over the years, Gilmartin's holdings reflected his direct connection to Merck's performance, showcasing how executive compensation can be tied closely to company success and market actions.